sglt2 inhibitors and glp 1 receptor agonists SGLT-2 GLP-1 in metabolic dysfunction-associated fatty liver disease GLP-1 receptor agonists and SGLT2

GLP-1 analogues have been shown in clinical trials to improve metabolic health and significantly reduce body weight

While the cost of GLP-1 coverage is top of mind for employers right now, they should not forget to factor in the significant cost of obesity-related complications, said Elina Onitskansky, the founder and CEO of obesity treatment company Ilant Health

Lilly Launches Trulicity in the US First Ever Ready-to-Use Once-Weekly GLP-1 Receptor Agonist Eli Lilly launches Trulicity in the US first ready-to-use once-weekly GLP-1, available with a savings program for commercially insured patients

PubMed Systematic reviewGLP-1 class evidence2025 Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference A broad meta-analysis anchor for GLP-1 weight-loss effect and class-level comparisons

They may also support heart and kidney health